Laboratory of Pharmacoepidemiology, Consorzio Mario Negri Sud, Via Nazionale 8, Santa Maria Imbaro (CH), Italy.
Eur Heart J. 2012 Feb;33(4):515-22. doi: 10.1093/eurheartj/ehr410. Epub 2011 Nov 16.
Aims Epidemiological studies reported two contrasting trends: on one hand, a significant improvement in the use of evidence-based treatments of patients discharged with a myocardial infarction (MI). On the other hand, the increasing number of elderly and co-morbid patients who are usually less treated. The aim of this study is to examine whether improvements in the treatment of MI are homogeneously distributed throughout all subgroups of patients. Methods and results Based on record linkage of administrative registers, 21 423 patients discharged with MI in three different periods (2003, 2005, and 2007), were identified and followed up for major clinical events up to 1 year. Using as a reference temporal category those patients discharged in 2003 (odds ratios, 95% confidence intervals) and as a demographic category male patients aged ≤75 years (1.00), the study identified: in-hospital mortality significantly decreased in all periods and in all groups of patients; out-of-hospital mortality decreased only in younger patients and not in older patients; prescription of evidence-based treatments increased in all periods for all patients; however, the magnitude of improvement was mostly concentrated in younger patients. Conclusion Although there was a mean improvement in the treatment and outcome of patients discharged from an MI, most of these benefits were strongly concentrated in younger, healthier patients. Old and co-morbid populations-although representing a substantial proportion of the burden of disease-received significant less attention and barely improved their survival.
目的 流行病学研究报告了两种相反的趋势:一方面,出院的心肌梗死(MI)患者接受循证治疗的比例显著提高。另一方面,越来越多的老年和合并症患者接受的治疗较少。本研究旨在检验 MI 治疗的改善是否均匀分布在所有患者亚组中。
方法和结果 基于行政登记记录的链接,确定了三个不同时期(2003 年、2005 年和 2007 年)出院的 21423 例 MI 患者,并对其进行了 1 年的主要临床事件随访。以 2003 年出院的患者作为时间参照类别(比值比,95%置信区间),以年龄≤75 岁的男性患者作为人口统计学类别(1.00),研究发现:住院死亡率在所有时期和所有患者亚组中均显著下降;院外死亡率仅在年轻患者中下降,而在老年患者中未下降;所有患者在所有时期都增加了循证治疗的处方;然而,改善的幅度主要集中在年轻患者中。
结论 尽管 MI 出院患者的治疗和结局平均有所改善,但这些获益主要集中在年轻、健康的患者中。尽管老年和合并症人群占疾病负担的很大比例,但他们得到的关注明显较少,生存状况几乎没有改善。